Klaus Urbahns



	Merck KGaA Bayer Aktiengesellschaft Discovery Technologies Medicinal Chemistry Michael PDF Andreas Ebel Frank Mauler

News

(1 - 4 von 8

–alle anzeigen

)

Adding Artificial Intelligence to Drug Discovery

www.genengnews.com

There’s nothing occult about today’s pharmacomancy. It simply automates data analysis and the identification of causal relationships. But for drug discovery,...

Merck and Iktos collaborate on compounds | Drug Discovery News

www.drugdiscoverynews.com

Agreement grants Merck KGaA access to Iktos’ AI technology across three drug discovery projects

New funding Period | Chemical Genomics Centre

www.cgc.mpg.de

Dr. Klaus Urbahns Head of Discovery & Development Technologies - Global Research & Development, Biopharma - Merck Merck has already been part of the ...

Wie Neugier Wissenschaftler antreibt | Merckwww.merckgroup.com › stories › how-curiosity-drives-scientists

www.merckgroup.com

Klaus Urbahns, Head of Discovery and Development Technologies, fasst zusammen: „Was zählt ist Neugier und die einzigartige Chance, mit modernen ...

Klaus Urbahns' berufliches Profil anzeigen LinkedIn ist das weltweit größte berufliche Netzwerk, das Fach- und Führungskräften wie Klaus Urbahns dabei hilft, interne Kontakte zu finden, die mit empfohlenen Kandidaten, Branchenexperten und potenziellen Geschäftspartnern verbunden sind.

Interessen

Klaus Urbahns - Patents

www.freshpatents.com

Klaus Urbahns - bibliographic patent references Recent bibliographic sampling of patent applications for Klaus Urbahns listed/published in the public domain by the

Private Homepages

Klaus Urbahns's Email & Phone - Merck Group - Frankfurt Am Main Area,...

contactout.com

Klaus Urbahns's Email. Show email and phone number. Frankfurt Am Main Area, Germany. Global Head of Discovery Technologies @ Merck Group. Global...

Bücher

(1 - 4 von 5

–alle anzeigen

)

Aspects of Organic Chemistry: Structure - Gerhard Quinkert, Ernst...

books.google.de

Petra Schmalz, Claudia Schierloh, Astrid Db'ring, Dietmar Reichert, Klaus Urbahns, and Birgit Gro'ne were especially invaluable here. From the collected notes ...

AACR 2016: Abstracts American Association for Cancer...

books.google.com.au

The AACR Annual Meeting is a must-attend event for cancer researchers and the broader cancer community. This year's theme, "Delivering Cures Through...

AACR Proceedings: Abstracts American Association for...

books.google.com.au

The AACR Annual Meeting highlights the best cancer science and medicine from institutions all over the world. Attendees are invited to stretch their...

Official Gazette of the United States Patent and Trademark Office:...

books.google.co.uk

... Cl. 560–83 Klaus Urbahns, Wuppertal, and Frank Mauler, Overath, both of Germany, assignors Leverkusen, Germany to Bayer Aktiengesellschaft, PCT No.

Dokumente zum Namen

(1 - 4 von 5

–alle anzeigen

)

Klaus Urbahns - Academia.edu

independent.academia.edu

Academia.edu is a place to share and follow research.

Biphenyls as potent vitronectin receptor antagonists

pdfslide.us

Biphenyls as Potent Vitronectin Receptor Antagonists Klaus Urbahns,a,* Michael Ha¨rter,a Markus Albers,b Delf Schmidt,c Beatrix Stelte-Ludwig,d Ulf...

Kleine Moleküle, ganz groß: niedermolekulare immunonkologische...

www.deepdyve.com

Immunonkologische Therapien haben das Potenzial, das Arsenal klinisch verfügbarer Tumortherapien nachhaltig zu verändern. Um die bisher erzielten klinischen...

IKCa-channel blockers. Part 2: Discovery of cyclohexadienes - [PDF...

vdocuments.mx

IKCa-channel blockers. Part 2: D Klaus Urbahns,a,* Siegfried Goldmann Joachim Schuhmacher,c Rolf Grosser,a aInstitute of Medicinal Chemistry, Pharma Research...

Wissenschaftliche Veröffentlichungen

Bioorganic & Medicinal Chemistry Letters | Vol 13, Issue 16, Pages...

www.sciencedirect.com

4-Phenyl-4H-pyrans as IKCa channel blockers. Klaus Urbahns, Ervin Horváth, Johannes-Peter Stasch, Frank Mauler. Pages : Download PDF.

Report on the 6th scientific meeting of the “Verein zur Förderung des...

etsmjournal.biomedcentral.com

Klaus Urbahns, Discovery Technologies, Merck KGaADarmstadt, Germany. Marie Wunsch, Institut für Anatomie ...

Lisa Ruhfus bei Merck - Forschung ist die beste Medizinwww.forschung-ist-die-beste-medizin.de › botschafter › lisa-ruhfus-be...

www.forschung-ist-die-beste-medizin.de

Klaus Urbahns studierte Chemie an den Universitäten Kiel und Freiburg und promovierte in Organischer Chemie an der Universität Frankfurt am ...

Veröffentlichungen allgemein

Report on the 6th scientific meeting of the “Verein zur Förderung des...

link.springer.com

From October 31th – November 2nd, 2014, the 6th NEUROWIND e.V. meeting was held in Motzen, Brandenburg, Germany. 70 doctoral students and postdocs from over

Artikel & Meinungen

Wikipedia: Gerhard Quinkert – Wikipedia

Gerhard Quinkert, Stefan Scherer, Dietmar Reichert, Hans-Peter Nestler, Helma Wennemers, Andreas Ebel, Klaus Urbahns, Klaus Wagner, Klaus-Peter ...

Sonstiges

(1 - 20 von 32

–alle anzeigen

)

Klaus Urbahns - SVP, Global Head of Discovery and LinkedIn

www.linkedin.com

View Klaus Urbahns' profile on LinkedIn, the world's largest professional community. Klaus has 4 jobs listed on their profile. See the complete profile on LinkedIn ...

CA A1 - Stents with vitronectin receptor antagonists against...

patents.google.com

Bayer HealthCare AG; Original Assignee: Bayer Healthcare Ag: Klaus Urbahns: Christoph Gerdes: Susanne Zuleger: Sabine Gelfert-Peukert: Jeffrey Low ...

CA A1 - Dimethyl-substituted cyclohexane diene derivatives...

patents.google.com

Priority to DE Application filed by Bayer Aktiengesellschaft, Klaus Urbahns, Frank Mauler Publication of CA A1.

CA A1 - Fused azole-pyrimidine derivatives Google...

patents.google.com

... Omori, Issei Kato, Mami Miura, Klaus Urbahns, Florian Gantner, Kevin Bacon ... Klaus Urbahns, Florian Gantner, Bayer Aktiengesellschaft, Bayer Healthcare ...

Dr. Klaus Urbahns | 27th Annual Conference

www.ae2015.eu

Local Information · Sight Seeing · Restaurants · Contact · Legal notice. Dr. Klaus Urbahns. Merck Group. Unleash the Beast! - Immunotherapies for Cancer.

Klaus Urbahns - Currntcurrnt.com › @Klaus_Urbahns

currnt.com

Klaus Urbahns. SVP, Discovery Technologies. Frankfurt Am Main Area, Germany. Focus: Contributions are valued by peers; Accountability: Thoroughly ...

WO A1 - Verwendung von 5-substituierten pyridin- und...

patents.google.com

Die Erfindung betrifft die Verwendung von teilweise bekannten 5-substituierten Pyridin- und Hexahydrochinolin-3-carbonsäurederivaten zur Herstellung von...

US B1 - 1,4-benzodiazepinone derivatives and their use as...

patents.google.com

US Grant. Download PDF Find Prior Art. Inventor: Klaus Urbahns: Delf Schmidt: Ulf Brüggemeier: Christoph Gerdes: Beatrix Stelte-Ludwig: Jörg Keldenich: Elke ...

Klaus Urbahns, Pfungstadt

www.northdata.de

Handelsregisterbekanntmachungen und Netzwerk zu Klaus Urbahns, Pfungstadt: Merck Healthcare KGaA, vormals: Merck KGaA.

Marco Skrinjar, and Klaus Urbahns 3 - PDF Free Download

docplayer.net

J. Med. Chem , 52, DOI: /jm y Increasing Selectivity of CC Chemokine Receptor 8 Antagonists by Engineering Nondesolvation Related ...

www.infona.pl

Klaus Urbahns. Details · Publications ... Klaus Urbahns, Takeshi Yura, Jang B. Gupta, Masaomi Tajimi, more · Bioorganic & Medicinal ...

US A1 - Stents with vitronectin receptor antagonists...

patents.google.com

The application relates to vitronectin receptor antagonist-containing stents and to their production and use

2,8-Disubstituted-1,6-Naphthyridines and 4,6-Disubstituted ...

figshare.com

... Michael Busch Richard Schneider Daniel Schwarz Djordje Musil Rosemary Burke Klaus Urbahns Paul Workman Dirk Wienke Paul A. Clarke ...

Altmetric – Small Molecules Drive Big Improvements in Immuno-Oncology...

wiley.altmetric.com

Urbahns, Klaus, Huck, Bayard R., Kötzner, Lisa, Huck, Bayard R., Dr. Bayard R. Huck, Dr. Lisa Kötzner, Dr. Klaus Urbahns. Abstract. Immuno-oncology therapies ...

Application data

www1.epa.ee

Inventor name: Klaus Urbahns (DE) Hans-Georg Heine (DE) Bodo Junge (DE) Frank Mauler (DE) Thomas Glaser (DE) Reilinde Wittka (DE)

Biphenyls as potent vitronectin receptor antagonists. Part 3: Squaric...

www.infona.pl

Klaus Urbahns. Institute of Medicinal Chemistry, Bayer Healthcare AG, Bayer-Schering Pharma, Wuppertal, Germany ...

(PDF) Biphenyls as potent vitronectin receptor antagonists. Part 2:...

www.academia.edu

Bioorganic & Medicinal Chemistry Letters 13 (2003) 1071–1074 Biphenyls as Potent Vitronectin Receptor Antagonists. Part 2: Biphenylalanine Ureas Klaus Urbahns,a,* Michael Ha¨rter,a Andrea Vaupel,a Markus Albers,b Delf Schmidt,c Ulf Bru¨ggemeier,c Beatrix Stelte-Ludwig,d Christoph Gerdesd and Hideki Tsujishita,e ...

Verwandte Suchanfragen zu Klaus Urbahns

Daniel Schwarz
Helma Wennemers
Andreas Ebel

Christoph Gerdes
Hans-Peter Nestler
Klaus Wagner

Günter Prescher
Paul Czodrowski
Bertram Cezanne

Personen
Vorname "Klaus" (65148)
Name "Urbahns" (9)

sortiert nach Relevanz / Datum

Erweiterte Suche

Dossier exportieren

Person-Suchen: A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Klaus Urbahns Person-Info

Interessen

Private Homepages

Wissenschaftliche Veröffentlichungen

Veröffentlichungen allgemein

Artikel & Meinungen